Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.160
+0.070 (3.35%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Lipocine Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Lipocine stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 131.48% higher than the current stock price, while the lowest is $4.00 (+85.19%) and the highest is $6.00 (+177.78%).
Price Target: $5.00 (+131.48%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lipocine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $4 | Hold | Reiterates | $4 | +85.19% | Sep 21, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $6 | Buy | Maintains | $6 | +177.78% | Aug 5, 2026 |
Financial Forecast
Revenue This Year
631.25K
from 1.98M
Decreased by -68.07%
Revenue Next Year
745.00K
from 631.25K
Increased by 18.02%
EPS This Year
9.01
EPS Next Year
10.03
from 9.01
Increased by 11.32%
EPS and Forward PE are based on non-GAAP adjusted numbers.